Recruiting

Electrocorticography Signals

Sponsor:

University of Washington

Code:

NCT03289572

Conditions

Epilepsy Intractable

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Neurologic disease with loss of motor function is a major health burden. Brain-computer interfaces (BCI) are systems that use brain signals to power an external device, such as a communication board or a prosthetic device, which may help people with loss of motor function. Electrocorticography (ECoG) has been used to decode hand movements and as a control signal for brain-computer interface (BCI). This study hopes to use a smaller spacing of ECoG to see if a better motor signal can be found and used as a BCI control signal.

Conditions

Epilepsy Intractable

Study ID

NCT03289572

Start date

Nov, 2015

Status verified date

Apr, 2021

Completion date

Dec, 2024

Anticipated

Primary completion date

Dec, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Must be able to speak and read English
  • Cognitive ability to follow study directions
  • Patients that are scheduled to undergo grid placement clinically for treatment of
  • intractable epilepsy
  • 18 years of age or older

Exclusion Criteria:

  • Patients who are not considered candidates for epilepsy surgery
  • Individuals who have a diagnosis that would not allow them to participate in research procedures. For example, a physical disability that would limit hand movements and range of motion.

Study Design

Enrollment

20 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • This is an observational study and the outcome is successful measurement of motor-related corticography signals. [ Time Frame: 7-10 days ]

Central Contacts and Locations

Central contacts

Amy m Anderson, BSN

206-744-9364amya9@uw.edu

Locations

Harborview Medical Center

Recruiting

Seattle, Washington, United States, 98104

Contacts

Amy Anderson

206-744-9364amya9@uw.edu

Principal Investigator:

Jeffrey G Ojemann, MD

More Information

Sponsor

University of Washington

Last update posted

Apr 27, 2021

Last verified

Apr, 2021

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-23. This information was provided to ClinicalTrials.gov by University of Washington on 2021-04-27.